Refine by
Real Time Microchip Based Pcr Articles & Analysis
49 news found
As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has introduced its efficient and precise Microbial Genome Editing services to support researchers in the modification of specific target genes within an organism's genome.Microbial cell factories are a promising mode of production for fuels, chemicals, and pharmaceuticals because microbial ...
The New York City Department of Health and Mental Hygiene (NYC Health) warns that tuberculosis (TB) is still a life-threatening problem in the city. As recently as 2022, the agency reports there were 536 confirmed TB cases, including some involving multi-drug resistant (MDR) TB, and that 100% of NYC neighborhoods had at least one TB case. TB is caused by a bacterium known as Mycobacterium ...
Amerigo Scientific, as a distributor focused on providing critical products and services to biomedical and life science communities, recently rolled out their cutting-edge real-time PCR kits for Hepatitis A virus (HAV) research. The new kits offer researchers excellent accuracy, sensitivity, and convenience in studying and analyzing HAV samples. Hepatitis A is a highly contagious viral ...
In vitro diagnostics (IVD) are tests done on samples such as blood or tissue for the purpose of detecting diseases or other conditions. To facilitate efforts on IVD research, the US-based chemical supplier Alfa Chemistry has recently introduced three IVD products for laboratory use, adding to its already diverse range of biological reagents. The biological reagents previously launched by Alfa ...
Amerigo Scientific, a distributor focused on providing critical products and services to biomedical and life science communities, unveils 1Step RT PCR Kit for the scientific use of gene-expression analysis, transfection analysis, cDNA cloning, multiplex RT-PCR, etc. The size of this kit is 100 reactions of 50 µl and available in bulk. PCR is a technique used for DNA amplification. Discovered by ...
According to the report of World Health Organization (WHO) on May 21, more than 120 confirmed or suspected cases of monkeypox, a rare viral disease seldom detected outside Africa, have been reported in at least 12 non-epidemic countries around the world, including more than 20 confirmed cases in Portugal, Spain and the UK. At present, there are no relevant death cases. There is evidence that ...
FireGene announces that its Monkeypox Virus Nucleic Acid Detection Kit (Real-time Fluorescent PCR Method) has recently obtained CE-IVDD approval. This RT-PCT kit can be used to detect suspected cases of MPV infection. Rash fluid, nasopharyngeal swabs, pharyngeal swabs, and serum samples are applicable for the test. The test result is available in 40 minutes after sample collection. This kit is ...
ByFireGene
Immundiagnostik's respiratroy PCR assays MutaPLEX® Coronavirus (KG1926), MutaPLEX® RespiraScreen 1 (KG1927), MutaPLEX® RespiraScreen 2 DIFF (KG1928) and MutaPLEX® Coronavirus 4G (KG1936) were screened for the spike protein mutations in the following viral variants: [Omicron] (BA.1, BA.2, BA.4, BA.5) [Omicron] (BA.3, BA.2 + L452X) [Alpha], [Beta], [Gamma], [Delta] (all AY ...
Virusight Diagnostic, a world leader in combining artificial intelligence software and spectral technology today announced the results of a major clinical study that found its ultra-rapid, point of care Pathogens Diagnostic solution consistently delivers 96.3% accuracy when compared to the gold standard RT-PCR. The study was conducted by the Department of Science and Technology, University of ...
The Test is now available for use across Europe and other countries that accept CE-IVD marking, providing a powerful pandemic and endemic management tool in industries where fast and reliable decentralized testing is crucial. With the launch of its first product, miDiagnostics enters the commercial phase, marking an important milestone in the company’s development. Ultra-fast and reliable ...
As a global leading supplier of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics recently launches a series of NiV recombinant antigen and antibody pairs. All of these new products are produced using standardized production processes to ensure the highest quality. Tests developed using these reagents can assist researchers in routine diagnostics and NiV ...
MicrobioSeq represents the microbial genomics division of CD Genomics, headquartered in New York, USA. CD Genomics MicrobioSeq is committed to delivering comprehensive microbial solutions to human health, agriculture, the environment, and industry by characterizing microbiomes and leveraging microorganisms. The company has recently announced the launch of PCR-based microbial antibiotic resistance ...
Biocon Ltd (BSE code: 532523, NSE: BIOCON), an innovation-led global biopharmaceuticals company, today announced its consolidated financial results for the third quarter ended December 31, 2021. Commenting on the results, Kiran Mazumdar-Shaw, Executive Chairperson, Biocon, said, “Biocon’s consolidated Q3FY22 revenues grew by 18% YoY to Rs 2,223 Crore, driven by a strong performance ...
ByBiocon
Thermo Fisher Scientific, the world leader in serving science, today announced an update to its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to enable direct detection of the Omicron SARS-CoV-2 variant. The panel is designed with a customizable menu of real-PCR genotyping assays to accurately identify known SARS-COV-2 variants in just over an hour. South African researchers first ...
The majority takeover of terraplasma medical GmbH by Viromed Plasma GmbH, a member of the Viromed Group, was announced today. terraplasma GmbH will continue to hold shares in terraplasma medical GmbH in order to contribute its expertise in the field of cold atmospheric plasmas in the future. The common goal of Viromed and terraplasma is to establish terraplasma medical as the world's leading ...
BioGX, a global provider of molecular diagnostic solutions, announced that the Omicron (B.1.1.529), the latest emerging SARS-CoV-2 variant of concern, will be detected by the portfolio of BioGX SARS-CoV-2 products that target the nucleocapsid (N-gene) and envelope (E-gene) for detection of the virus. BioGX’s SARS-CoV-2 surveillance program includes exhaustive in-silico analysis and ...
As assay developers and clinical testing laboratories consider next steps for molecular diagnostics post-pandemic, a new in vitro diagnostic (IVD) system from Thermo Fisher Scientific will enable them to expand their assay menus and IVD testing capabilities moving forward. The Applied Biosystems QuantStudio 7 Pro Dx Real-Time PCR System is a compact instrument that easily transitions from ...
Lumex Instruments has developed a rapid modern solution to distinguish COVID-19, Influenza A, and B from the same sample.* It is imperative to differentiate and identify the exact causative virus for appropriate therapeutic intervention, especially during the current COVID-19 pandemic. The solution employs a pre-loaded microchip kit with the primers and probes lyophilized in the microchip for ...
Despite the slow evolutionary rate of SARS-CoV-2 relative to other RNA viruses, its massive and rapid transmission during the COVID-19 pandemic has enabled it to acquire significant genetic diversity since it first entered the human population. This led to the emergence of numerous variants, some of them recently being labeled “variants of concern” (VOC), due to their potential impact ...
AZOVA Inc., creator of the world’s most comprehensive digital health network for COVID-19 testing and vaccination management, and Ellume, the company to bring the first non-prescription over-the-counter COVID-19 home test to market, today announced an official partnership with Alaska Airlines to provide a convenient, at-home rapid testing solution for its passengers. The Ellume COVID-19 ...